LONG BEACH, Calif.--(BUSINESS WIRE)--Obagi Medical Products, Inc. (NASDAQ: OMPI), a leader in topical aesthetic and therapeutic skin health systems, today reported that net sales for the third quarter of 2010 rose 12.0% to $27.9 million, from $24.9 million in the third quarter a year ago.
